ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bill Gates invests in Alzheimer’s research

by Michael McCoy
November 20, 2017 | APPEARED IN VOLUME 95, ISSUE 46

Microsoft cofounder Bill Gates has put $50 million into the Dementia Discovery Fund, a venture capital fund that invests in new drugs for Alzheimer’s disease and other forms of dementia. Gates told the news organization Reuters that he will also invest $50 million directly in start-ups researching Alzheimer’s. In his blog, Gates points to the finding that people have a nearly 50% chance of developing the disease if they live into their mid-80s.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment